|
[1]TANDON P, NEY M, IRWIN I, et al. Severe muscle depletion in patients on the liver transplant wait list:Its prevalence and independent prognostic value[J]. Liver Transpl, 2012, 18 (10) :1209-1216.
|
|
[2]MONTANO-LOZA AJ, MEZA-JUNCO J, PRADO CM, et al.Muscle wasting is associated with mortality in patients with cirrhosis[J]. Clin Gastroenterol Hepatol, 2012, 10 (2) :166-173. e1.
|
|
[3]PERIYALWAR P, DASARATHY S. Malnutrition in cirrhosis:Contribution and consequences of sarcopenia on metabolic and clinical responses[J]. Clin Liver Dis, 2012, 16 (1) :95-131.
|
|
[4]ROSENBERG IH. Sarcopenia:Origins and clinical relevance[J]. J Nutr, 1997, 127 (5 Suppl) :990S-991S.
|
|
[5] CRUZ-JENTOFT AJ, BAEYENS JP, BAUER JM, et al. Sarcopenia:European consensus on definition and diagnosis:Report of the European Working Group on Sarcopenia in older people[J]. Age Ageing, 2010, 39 (4) :412-423.
|
|
[6]FIELDING RA, VELLAS B, EVANS WJ, et al. Sarcopenia:An undiagnosed condition in older adults. Current consensus definition:prevalence, etiology, and consequences. International working group on sarcopenia[J]. J Am Med Dir Assoc, 2011, 12 (4) :249-256.
|
|
[7]ALBERINO F, GATTA A, AMODIO P, et al. Nutrition and survival in patients with liver cirrhosis[J]. Nutrition, 2001, 17 (6) :445-450.
|
|
[8]CAMPILLO B, PAILLAUD E, UZAN I, et al. Value of body mass index in the detection of severe malnutrition:Influence of the pathology and changes in anthropometric parameters[J].Clin Nutr, 2004, 23 (4) :551-559.
|
|
[9]MERLI M, GIUSTO M, GENTILI F, et al. Nutritional status:Its influence on the outcome of patients undergoing liver transplantation[J]. Liver Int, 2010, 30 (2) :208-214.
|
|
[10]PENG S, PLANK LD, MCCALL JL, et al. Body composition, muscle function, and energy expenditure in patients with liver cirrhosis:A comprehensive study[J]. Am J Clin Nutr, 2007, 85 (5) :1257-1266.
|
|
[11]MERLI M, GIUSTO M, LUCIDI C, et al. Muscle depletion increases the risk of overt and minimal hepatic encephalopathy:Results of a prospective study[J]. Metab Brain Dis, 2013, 28 (2) :281-284.
|
|
[12]MERLI M, LUCIDI C, GIANNELLI V, et al. Cirrhotic patients are at risk for health care-associated bacterial infections[J].Clin Gastroenterol Hepatol, 2010, 8 (11) :979-985.
|
|
[13]HUISMAN EJ, TRIP EJ, SIERSEMA PD, et al. Protein energy malnutrition predicts complications in liver cirrhosis[J]. Eur J Gastroenterol Hepatol, 2011, 23 (11) :982-989.
|
|
[14]SHIRAKI M, NISHIGUCHI S, SAITO M, et al. Nutritional status and quality of life in current patients with liver cirrhosis as assessed in 2007-2011[J]. Hepatol Res, 2013, 43 (2) :106-112.
|
|
[15]MONTANO-LOZA AJ, DUARTE-ROJO A, MEZA-JUNCO J, et al. Inclusion of sarcopenia within MELD (MELD-Sarcopenia) and the prediction of mortality in patients with cirrhosis[J]. Clin Transl Gastroenterol, 2015, 6:e102.
|
|
[16]NARDELLI S, LATTANZI B, TORRISI S, et al. Sarcopenia is risk factor for development of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt placement[J].Clin Gastroenterol Hepatol, 2017, 15 (6) :934-936.
|
|
[17]MONTANO-LOZA AJ, MEZA-JUNCO J, BARACOS VE, et al. Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation[J]. Liver Transpl, 2014, 20 (6) :640-648.
|
|
[18]MASUDA T, SHIRABE K, IKEGAMI T, et al. Sarcopenia is a prognostic factor in living donor liver transplantation[J]. Liver Transpl, 2014, 20 (4) :401-407.
|
|
[19]FUJIWARA N, NAKAGAWA H, KUDO Y, et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma[J]. J Hepatol, 2015, 63 (1) :131-140.
|
|
[20]ITOH S, SHIRABE K, YOSHIZUMI T, et al. Skeletal muscle mass assessed by computed tomography correlates to muscle strength and physical performance at a liver-related hospital experience[J]. Hepatol Res, 2016, 46 (4) :292-297.
|
|
[21]GOODPASTER BH, KELLEY DE, THAETE FL, et al. Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content[J]. J Appl Physiol (1985) , 2000, 89 (1) :104-110.
|
|
[22]SHEN W, PUNYANITYA M, WANG Z, et al. Total body skeletal muscle and adipose tissue volumes:Estimation from a single abdominal cross-sectional image[J]. J Appl Physiol (1985) , 2004, 97 (6) :2333-2338.
|
|
[23]WELLS CI, MCCALL JL, PLANK LD. Relationship between total body protein and cross-sectional skeletal muscle area in liver cirrhosis is influenced by overhydration[J]. Liver Transpl, 2019, 25 (1) :45-55.
|
|
[24]PRADO CM, LIEFFERS JR, MCCARGAR LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts:A population-based study[J]. Lancet Oncol, 2008, 9 (7) :629-635.
|
|
[25]CAREY EJ, LAI JC, WANG CW, et al. A multicenter study to define sarcopenia in patients with end-stage liver disease[J]. Liver Transpl, 2017, 23 (5) :625-633.
|
|
[26]YOSHIZUMI T, SHIRABE K, NAKAGAWARA H, et al. Skeletal muscle area correlates with body surface area in healthy adults[J]. Hepatol Res, 2014, 44 (3) :313-318.
|
|
[27]PENG TC, WU LW, CHEN WL, et al. Nonalcoholic fatty liver disease and sarcopenia in a Western population (NHANES III) :The importance of sarcopenia definition[J]. Clin Nutr, 2017.[Epub ahead of print]
|
|
[28]TSIEN CD, MCCULLOUGH AJ, DASARATHY S. Late evening snack:Exploiting a period of anabolic opportunity in cirrhosis[J]. J Gastroenterol Hepatol, 2012, 27 (3) :430-441.
|
|
[29]THAPALIYA S, RUNKANA A, MCMULLEN MR, et al. Alcohol-induced autophagy contributes to loss in skeletal muscle mass[J]. Autophagy, 2014, 10 (4) :677-690.
|
|
[30]TSIEN C, DAVULURI G, SINGH D, et al. Metabolic and molecular responses to leucine-enriched branched chain amino acid supplementation in the skeletal muscle of alcoholic cirrhosis[J]. Hepatology, 2015, 61 (6) :2018-2029.
|
|
[31]European Association for the Study of the Liver. EASL clinical practice guidelines on nutrition in chronic liver disease[J]. J Hepatol, 2019, 70 (1) :172-193.
|
|
[32]MONTANO-LOZA AJ. Clinical relevance of sarcopenia in patients with cirrhosis[J]. World J Gastroenterol, 2014, 20 (25) :8061-8071.
|
|
[33]ANAND AC. Nutrition and muscle in cirrhosis[J]. J Clin Exp Hepatol, 2017, 7 (4) :340-357.
|
|
[34]MANDERS RJ, LITTLE JP, FORBES SC, et al. Insulinotropic and muscle protein synthetic effects of branched-chain amino acids:Potential therapy for type 2 diabetes and sarcopenia[J]. Nutrients, 2012, 4 (11) :1664-1678.
|
|
[35]DASARATHY S, MERLI M. Sarcopenia from mechanism to diagnosis and treatment in liver disease[J]. J Hepatol, 2016, 65 (6) :1232-1244.
|
|
[36]DAVULURI G, KROKOWSKI D, GUAN BJ, et al. Metabolic adaptation of skeletal muscle to hyperammonemia drives the beneficial effects of l-leucine in cirrhosis[J]. J Hepatol, 2016, 65 (5) :929-937.
|
|
[37]BORACK MS, VOLPI E. Efficacy and safety of leucine supplementation in the elderly[J]. J Nutr, 2016, 146 (12) :2625S-2629S.
|
|
[38]KITAJIMA Y, TAKAHASHI H, AKIYAMA T, et al. Supplementation with branched-chain amino acids ameliorates hypoalbuminemia, prevents sarcopenia, and reduces fat accumulation in the skeletal muscles of patients with liver cirrhosis[J]. J Gastroenterol, 2018, 53 (3) :427-437.
|
|
[39]YOSHIMURA Y, BISE T, SHIMAZU S, et al. Effects of a leucine-enriched amino acid supplement on muscle mass, muscle strength, and physical function in post-stroke patients with sarcopenia:A randomized controlled trial[J]. Nutrition, 2018, 58:1-6.
|
|
[40]SMITH GI. The effects of dietary omega-3s on muscle composition and quality in older adults[J]. Curr Nutr Rep, 2016, 5 (2) :99-105.
|
|
[41]RODE A, FOURLANOS S, NICOLL A. Oral vitamin D replacement is effective in chronic liver disease[J]. Gastroenterol Clin Biol, 2010, 34 (11) :618-620.
|
|
[42]MALHAM M, JORGENSEN SP, OTT P, et al. Vitamin D deficiency in cirrhosis relates to liver dysfunction rather than aetiology[J]. World J Gastroenterol, 2011, 17 (7) :922-925.
|
|
[43]KITSON MT, ROBERTS SK. D-livering the message:The importance of vitamin D status in chronic liver disease[J]. J Hepatol, 2012, 57 (4) :897-909.
|
|
[44]de VITA F, LAURETANI F, BAUER J, et al. Relationship between vitamin D and inflammatory markers in older individuals[J]. Age (Dordr) , 2014, 36 (4) :9694.
|
|
[45]ROBINSON SM, REGINSTER JY, RIZZOLI R, et al. Does nutrition play a role in the prevention and management of sarcopenia?[J]. Clin Nutr, 2018, 37 (4) :1121-1132.
|
|
[46]POJEDNIC RM, CEGLIA L, OLSSON K, et al. Effects of 1, 25-dihydroxyvitamin D3 and vitamin D3 on the expression of the vitamin d receptor in human skeletal muscle cells[J]. Calcif Tissue Int, 2015, 96 (3) :256-263.
|
|
[47]DAVULURI G, ALLAWY A, THAPALIYA S, et al. Hyperammonaemia-induced skeletal muscle mitochondrial dysfunction results in cataplerosis and oxidative stress[J]. J Physiol, 2016, 594 (24) :7341-7360.
|
|
[48]KUMAR A, DAVULURI G, SILVA R, et al. Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasis[J]. Hepatology, 2017, 65 (6) :2045-2058.
|
|
[49]BAAR K. Training for endurance and strength:lessons from cell signaling[J]. Med Sci Sports Exerc, 2006, 38 (11) :1939-1944.
|
|
[50]BERZIGOTTI A, ALBILLOS A, VILLANUEVA C, et al. Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity:The Sport Diet study[J]. Hepatology, 2017, 65 (4) :1293-1305.
|
|
[51]DIETRICH R, BACHMANN C, LAUTERBURG BH. Exerciseinduced hyperammonemia in patients with compensated chronic liver disease[J]. Scand J Gastroenterol, 1990, 25 (4) :329-334.
|
|
[52]GARCIA-PAGAN JC, SANTOS C, BARBERA JA, et al. Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension[J]. Gastroenterology, 1996, 111 (5) :1300-1306.
|
|
[53]HIRAOKA A, MICHITAKA K, KIGUCHI D, et al. Efficacy of branched-chain amino acid supplementation and walking exercise for preventing sarcopenia in patients with liver cirrhosis[J]. Eur J Gastroenterol Hepatol, 2017, 29 (12) :1416-1423.
|
|
[54]SINCLAIR M, GROSSMANN M, HOERMANN R, et al. Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone:A randomised controlled trial[J]. J Hepatol, 2016, 65 (5) :906-913.
|
|
[55]NAGASUE N, YUKAYA H, CHANG YC, et al. Active uptake of testosterone by androgen receptors of hepatocellular carcinoma in humans[J]. Cancer, 1986, 57 (11) :2162-2167.
|
|
[56]OHARA M, OGAWA K, SUDA G, et al. L-Carnitine suppresses loss of skeletal muscle mass in patients with liver cirrhosis[J]. Hepatol Commun, 2018, 2 (8) :906-918.
|
DownLoad: